Skip to main content
. 2014 Oct 13;49(9):813–825. doi: 10.1310/hpj4909-813

Table 1. Biosimilars authorized in the European Uniona.

Biosimilar Active substance Manufacturerb Marketing authorization holder/applicant
Granulocyte colony-stimulating factors

Biograstim filgrastim Sicor Biotech UAB CT Arzneimittel GmbH
Filgrastim Hexal filgrastim Sandoz GmbH Hexal AG
Filgrastim ratiopharmc filgrastim Sicor Biotech UAB Ratiopharm GmbH
Grastofil filgrastim Intas Biopharmaceuticals Ltd.; Apotex Nederland BV Apotex Europe BV
Nivestim filgrastim Hospira Zagreb Hospira UK Ltd.
Ratiograstim filgrastim Sicor Biotech UAB Ratiopharm GmbH
Tevagrastim filgrastim Sicor Biotech UAB Teva Generics GmbH
Zarzio filgrastim Sandoz GmbH Sandoz GmbH

Erythropoietins

Abseamed epoetin alfa Rentschler Biotechnologie GmbH;
Lek Pharmaceuticals
Medice Arzneimittel
Pütter GmbH & Co. KG
Binocrit epoetin alfa Rentschler Biotechnologie GmbH;
Lek Pharmaceuticals
Sandoz GmbH
Epoetin Alfa Hexal epoetin alfa Rentschler Biotechnologie GmbH;
Lek Pharmaceuticals
Hexal AG
Retacrit epoetin zeta Norbitec GmbH Hospira UK Ltd.
Silapo epoetin zeta Norbitec GmbH Stada Arzneimittel AG

Growth hormones

Omnitrope somatropin Sandoz GmbH Sandoz GmbH
Valtropinc somatropin LG Life Sciences Ltd. BioPartners GmbH

Follicle-stimulating hormone

Bemfola follitropin alfa Polymun Scientific
Immunbiologische Forshung GmbH;
Finox Biotech AG
Finox Biotech AG
Ovaleap follitropin alfa Merckle Biotec GmbH;
Teva Pharmaceuticals;
Europe BV
Teva Pharma BV

Anti-human tumor necrosis factor alpha 2 monoclonal antibody

Inflectra infliximab Celltrion Inc. Hospira UK Ltd
Remsima infliximab Celltrion Inc. Celltrion Healthcare Hungary Kft
a

As of September 3, 2014.

b

The same biosimilar from one manufacturer (eg, Sicor Biotech UAB) may be marketed under different brand names.

c

Marketing authorization in the EU withdrawn at the request of the marketing authorization holder.